Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1)

L GOODMAN, B WAGNER, M FLAMINIO, K SUSSMAN, S METZGER, R HOLLAND, N OSTERRIEDER
  • Vaccine, April 2006, Elsevier
  • DOI: 10.1016/j.vaccine.2006.01.062

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1016/j.vaccine.2006.01.062

The following have contributed to this page: Laura Goodman